col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world

American Society for Microbiology: Microbiology Spectrum
  original article Date Title Authors   All Authors
1 [GO] 2021―Sep―15 Saliva SARS-CoV-2 Antibody Prevalence in Children Maya W. Keuning, Marloes Grobben, Anne-Elise C. de Groen, Eveline P. Berman-de Jong, Merijn W. Bijlsma, Sophie Cohen, et al. (+18)
2 [GO] 2021―Sep―15 A Multiplex Noninvasive Salivary Antibody Assay for SARS-CoV-2 Infection and Its Application in a Population-Based Survey by Mail Andrey I. Egorov, Shannon M. Griffin, Miyu Fuzawa, Jason Kobylanski, Rachel Grindstaff, William Padgett, et al. (+8)
3 [GO] 2021―Sep―15 Lower Incidence of Parvovirus-B19 Infections in Dutch Blood Donors during SARS-CoV-2 Pandemic M. W. Molenaar-de Backer, B. M. Hogema, M. H. Koppelman, T. J. van de Laar, E. Slot, H. L. Zaaijer, Rosemary C. She
4 [GO] 2021―Sep―08 The Reemergence of Seasonal Respiratory Viruses in Houston, Texas, after Relaxing COVID-19 Restrictions Parsa Hodjat, Paul A. Christensen, Sishir Subedi, David W. Bernard, Randall J. Olsen, S. Wesley Long, Heba H. Mostafa
5 [GO] 2021―Sep―08 Evaluation of a SARS-CoV-2 Capture IgM Antibody Assay in Convalescent Sera Binh Ha, Samadhan Jadhao, Laila Hussaini, Theda Gibson, Kathy Stephens, Luis Salazar, et al. (+9)
6 [GO] 2021―Sep―08 Analysis of the Role of N-Linked Glycosylation in Cell Surface Expression, Function, and Binding Properties of SARS-CoV-2 Receptor ACE2 Raymond Rowland, Alberto Brandariz-Nuñez, Ujjwal Neogi
7 [GO] 2021―Sep―01 Distinct Metabolic Profile Associated with a Fatal Outcome in COVID-19 Patients during the Early Epidemic in Italy Elisa Saccon, Alessandra Bandera, Mariarita Sciumè, Flora Mikaeloff, Abid A. Lashari, Stefano Aliberti, et al. (+18)
8 [GO] 2021―Sep―01 Targeted Hybridization Capture of SARS-CoV-2 and Metagenomics Enables Genetic Variant Discovery and Nasal Microbiome Insights Dorottya Nagy-Szakal, Mara Couto-Rodriguez, Heather L. Wells, Joseph E. Barrows, Marilyne Debieu, Kristin Butcher, et al. (+9)
9 [GO] 2021―Sep―01 Mild SARS-CoV-2 Illness Is Not Associated with Reinfections and Provides Persistent Spike, Nucleocapsid, and Virus-Neutralizing Antibodies Charles F. Schuler, Carmen Gherasim, Kelly O’Shea, David M. Manthei, Jesse Chen, Cristyn Zettel, et al. (+8)
10 [GO] 2021―Aug―25 Detection of SARS-CoV-2 Infection in Gargle, Spit, and Sputum Specimens Eero Poukka, Henna Mäkelä, Lotta Hagberg, Thuan Vo, Hanna Nohynek, Niina Ikonen, et al. (+5)
11 [GO] 2021―Aug―25 Comparison of SARS-CoV-2 PCR-Based Detection Using Saliva or Nasopharyngeal Swab Specimens in Asymptomatic Populations Guang Fan, Xuan Qin, Daniel N. Streblow, Cristina Magallanes Hoyos, Donna E. Hansel, William Lainhart
12 [GO] 2021―Aug―25 Molecular Mirror Technology Facilitates High-Throughput, Accurate SARS-CoV-2 Testing Susan Realegeno, Sara Hash, Charlene Wong, Roland Liu, Jovan Shepherd, Robert T. Schooley, et al. (+5)
13 [GO] 2021―Aug―25 Identification of Novel Mutations in the N Gene of SARS-CoV-2 That Adversely Affect the Detection of the Virus by Reverse Transcription-Quantitative PCR Rashedul Hasan, Mohammad Enayet Hossain, Mojnu Miah, Md Mahmudul Hasan, Mustafizur Rahman, Mohammed Ziaur Rahman, S. Wesley Long
14 [GO] 2021―Aug―18 Pre-Vaccine Positivity of SARS-CoV-2 Antibodies in Alberta, Canada during the First Two Waves of the COVID-19 Pandemic Carmen L. Charlton, Leonard T. Nguyen, Ashley Bailey, Jayne Fenton, Sabrina S. Plitt, Carol Marohn, et al. (+10)
15 [GO] 2021―Aug―18 Comprehensive Characterization of COVID-19 Patients with Repeatedly Positive SARS-CoV-2 Tests Using a Large U.S. Electronic Health Record Database Xiao Dong, Yujia Zhou, Xiao-ou Shu, Elmer V. Bernstam, Rebecca Stern, David M. Aronoff, et al. (+3)
16 [GO] 2021―Aug―18 Saliva is Comparable to Nasopharyngeal Swabs for Molecular Detection of SARS-CoV-2 Cody Callahan, Sarah Ditelberg, Sanjucta Dutta, Nancy Littlehale, Annie Cheng, Kristin Kupczewski, et al. (+5)
17 [GO] 2021―Aug―18 Erratum for Zhao et al., “Structural Basis and Function of the N Terminus of SARS-CoV-2 Nonstructural Protein 1” Kaitao Zhao, Zunhui Ke, Hongbing Hu, Yahui Liu, Aixin Li, Rong Hua, et al. (+9)
18 [GO] 2021―Aug―11 Performance Evaluation of the MatMaCorp COVID-19 2SF Assay for the Detection of SARS-CoV-2 from Nasopharyngeal Swabs Arryn Craney, Dustin Petrik, Ashley Suhku, Yuqing Qiu, Sabrina Racine-Brzostek, Hanna Rennert, et al. (+6)
19 [GO] 2021―Aug―11 TMPRSS2 and RNA-Dependent RNA Polymerase Are Effective Targets of Therapeutic Intervention for Treatment of COVID-19 Caused by SARS-CoV-2 Variants (B.1.1.7 and B.1.351) Jihye Lee, JinAh Lee, Hyeon Ju Kim, Meehyun Ko, Youngmee Jee, Seungtaek Kim, Cyprian C. Rossetto
20 [GO] 2021―Aug―11 Precision Response to the Rise of the SARS-CoV-2 B.1.1.7 Variant of Concern by Combining Novel PCR Assays and Genome Sequencing for Rapid Variant Detection and Surveillance Nathan Zelyas, Kanti Pabbaraju, Matthew A. Croxen, Tarah Lynch, Emily Buss, Stephanie A. Murphy, et al. (+5)
21 [GO] 2021―Aug―11 Mild and Severe SARS-CoV-2 Infection Induces Respiratory and Intestinal Microbiome Changes in the K18-hACE2 Transgenic Mouse Model Brittany Seibert, C. Joaquín Cáceres, Stivalis Cardenas-Garcia, Silvia Carnaccini, Ginger Geiger, Daniela S. Rajao, et al. (+3)
22 [GO] 2021―Aug―11 SARS-CoV-2 Isolates Show Impaired Replication in Human Immune Cells but Differential Ability to Replicate and Induce Innate Immunity in Lung Epithelial Cells Miao Jiang, Pekka Kolehmainen, Laura Kakkola, Sari Maljanen, Krister Melén, Teemu Smura, et al. (+3)
23 [GO] 2021―Aug―11 Understanding the Barriers to Pooled SARS-CoV-2 Testing in the United States Eli P. Fenichel, R. Tobias Koch, Anna Gilbert, Gregg Gonsalves, Anne L. Wyllie, Rosemary C. She
24 [GO] 2021―Aug―04 COVID-19 Cases from the First Local Outbreak of the SARS-CoV-2 B.1.1.7 Variant in China May Present More Serious Clinical Features: A Prospective, Comparative Cohort Study Yang Song, Ziruo Ge, Shuping Cui, Di Tian, Gang Wan, Shuangli Zhu, et al. (+14)
25 [GO] 2021―Aug―04 Evaluation of the INDICAID COVID-19 Rapid Antigen Test in Symptomatic Populations and Asymptomatic Community Testing Ricky Y. T. Chiu, Noah Kojima, Garrett L. Mosley, Kwok Kin Cheng, David Y. Pereira, Matthew Brobeck, et al. (+22)
26 [GO] 2021―Aug―04 Differential Antibody Response to mRNA COVID-19 Vaccines in Healthy Subjects Sarah E. Wheeler, Galina V. Shurin, Mary Yost, Adam Anderson, Lisa Pinto, Alan Wells, et al. (+2)
27 [GO] 2021―Aug―04 Transformations, Lineage Comparisons, and Analysis of Down-to-Up Protomer States of Variants of the SARS-CoV-2 Prefusion Spike Protein, Including the UK Variant B.1.1.7 Michael H. Peters, Oscar Bastidas, Daniel S. Kokron, Christopher E. Henze, Soo Chan Lee
28 [GO] 2021―Aug―04 SARS-CoV-2 Quasispecies Provides an Advantage Mutation Pool for the Epidemic Variants Fengming Sun, Xiuhua Wang, Shun Tan, Yunjie Dan, Yanqiu Lu, Juan Zhang, et al. (+11)
29 [GO] 2021―Jul―28 High-Throughput Multiplex SARS-CoV-2 IgG Microsphere Immunoassay for Dried Blood Spots: A Public Health Strategy for Enhanced Serosurvey Capacity Linda M. Styer, Rebecca Hoen, Jean Rock, Erica Yauney, Katherine Nemeth, Rachel Bievenue, et al. (+2)
30 [GO] 2021―Jul―21 Coinfections with Other Respiratory Pathogens among Patients with COVID-19 K. Sreenath, Priyam Batra, E. V. Vinayaraj, Ridhima Bhatia, KVP SaiKiran, Vishwajeet Singh, et al. (+9)
31 [GO] 2021―Jul―21 Inactivation of SARS-CoV-2 by Simulated Sunlight on Contaminated Surfaces Jérémy Raiteux, Marine Eschlimann, Audrey Marangon, Sophie Rogée, Maylis Dadvisard, Laurent Taysse, et al. (+2)
32 [GO] 2021―Jul―21 Durable Antibody Responses in Staff at Two Long-Term Care Facilities, during and Post SARS-CoV-2 Outbreaks Emily N. Gallichotte, Mary Nehring, Michael C. Young, Sierra Pugh, Nicole R. Sexton, Emily Fitzmeyer, et al. (+8)
33 [GO] 2021―Jul―14 Saliva Testing Is Accurate for Early-Stage and Presymptomatic COVID-19 Abigail J. Johnson, Shannon Zhou, Susan L. Hoops, Benjamin Hillmann, Matthew Schomaker, Robyn Kincaid, et al. (+7)
34 [GO] 2021―Jul―14 Self-Collected Gargle Lavage Allows Reliable Detection of SARS-CoV-2 in an Outpatient Setting Johannes Zander, Stephan Scholtes, Maximilian Ottinger, Marcel Kremer, Azadeh Kharazi, Vanessa Stadler, et al. (+5)
35 [GO] 2021―Jun―30 Anti-Spike Protein Assays to Determine SARS-CoV-2 Antibody Levels: a Head-to-Head Comparison of Five Quantitative Assays Thomas Perkmann, Nicole Perkmann-Nagele, Thomas Koller, Patrick Mucher, Astrid Radakovics, Rodrig Marculescu, et al. (+5)
36 [GO] 2021―Jun―16 Structural Basis and Function of the N Terminus of SARS-CoV-2 Nonstructural Protein 1 Kaitao Zhao, Zunhui Ke, Hongbing Hu, Yahui Liu, Aixin Li, Rong Hua, et al. (+10)
37 [GO] 2021―Jun―16 Spike Protein Antibodies Mediate the Apparent Correlation between SARS-CoV-2 Nucleocapsid Antibodies and Neutralization Test Results Thomas Perkmann, Thomas Koller, Nicole Perkmann-Nagele, Miriam Klausberger, Mark Duerkop, Barbara Holzer, et al. (+8)
38 [GO] 2021―Jun―13 Genomic and Phenotypic Analysis of COVID-19-Associated Pulmonary Aspergillosis Isolates of Aspergillus fumigatus Jacob L. Steenwyk, Matthew E. Mead, Patrícia Alves de Castro, Clara Valero, André Damasio, Renato A. C. dos Santos, et al. (+12)
39 [GO] 2021―May―31 Pandemics and People Michael J. Imperiale, Patricia A Bradford


[de][en]

Last change 2021―Sep―04 16:13:39 UTC

© Daten-Quadrat 2021       Done in 0.010 sec